C9-200
C9-200 is an ionizable cationic lipid that has been used in the formation of lipid nanoparticles (LNPs) . C9-200-based LNPs encapsulating mRNA encoding erythropoietin (EPO) can induced EPO production and stimulate red blood cell production in mice[1].
Product Specifications
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
CCCCCCCC(O)CN(CCN1CCN(CCN(CC(O)CCCCCCC)CC(O)CCCCCCC)CC1)CCN(CC(O)CCCCCCC)CC(O)CCCCCCC
Molecular Formula
C55H115N5O5
Molecular Weight
926.53
References & Citations
[1]Mrksich K, et al. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length. J Biomed Mater Res A. 2024 Sep;112 (9) :1494-1505.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-172335/
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1086122 Inquire
Recombinant Xanthobacter autotrophicus ATP synthase subunit alpha (atpA), partial
Ask
View Details 